Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Clene Inc. prices

Date Open High Low Close Volume
Mar 04, 2021 $13.38 $13.38 $10.83 $11.11 114 646
Mar 03, 2021 $13.64 $14.08 $13.21 $13.51 54 568
Mar 02, 2021 $13.66 $14.58 $13.59 $13.76 143 782
Mar 01, 2021 $13.15 $13.98 $12.94 $13.58 102 408
Feb 26, 2021 $12.70 $13.46 $12.61 $12.84 59 675
Feb 25, 2021 $14.59 $14.69 $12.63 $13.03 204 213
Feb 24, 2021 $13.54 $14.69 $13.18 $14.54 267 211
Feb 23, 2021 $13.61 $13.61 $12.56 $13.12 80 589
Feb 22, 2021 $14.00 $14.60 $13.60 $13.79 104 148
Feb 19, 2021 $13.95 $14.39 $13.30 $13.61 91 630
Feb 18, 2021 $14.40 $14.43 $13.35 $13.90 116 539
Feb 17, 2021 $15.66 $15.85 $13.40 $14.44 329 731
Feb 16, 2021 $12.56 $16.50 $12.56 $16.30 462 182
Feb 12, 2021 $10.86 $12.49 $10.40 $12.49 236 195
Feb 11, 2021 $10.86 $11.05 $10.73 $10.79 149 980
Feb 10, 2021 $10.10 $10.95 $9.95 $10.79 175 709
Feb 09, 2021 $11.13 $11.27 $10.60 $10.90 209 379
Feb 08, 2021 $10.75 $11.45 $10.50 $11.37 181 949
Feb 05, 2021 $11.00 $11.29 $10.38 $10.73 211 139
Feb 04, 2021 $13.05 $13.10 $10.32 $10.94 947 340
Feb 03, 2021 $7.75 $13.68 $7.75 $13.21 6 007 278
Feb 02, 2021 $6.59 $6.60 $6.38 $6.54 74 673
Feb 01, 2021 $6.50 $6.65 $6.23 $6.55 67 262
Jan 29, 2021 $6.65 $6.65 $6.30 $6.39 93 434
Jan 28, 2021 $6.40 $6.69 $6.36 $6.49 43 512
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT